[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fG4hSXHwqoAC6BsZJ4Co-60ngMYHZZt19k974cWFeAuk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Medtronic MiniMed, Inc.",[4],72,false,5,2,11199,0,70,[14,17,20,23,25,27,29,32],{"name":15,"count":16},"Type 1 Diabetes",31,{"name":18,"count":19},"Type 1 Diabetes Mellitus",14,{"name":21,"count":22},"Diabetes Mellitus, Type 1",6,{"name":24,"count":22},"Type 2 Diabetes",{"name":26,"count":22},"Type 2 Diabetes Mellitus",{"name":28,"count":8},"Diabetes",{"name":30,"count":31},"Diabetes Mellitus",4,{"name":33,"count":9},"Diabetes Mellitus, Type 2",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,71,89],{"intervention":44,"totalTrials":45,"cells":46},"Medtronic MiniMed Implantable Pump Human Recombinant Insulin",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":67,"NA":69},{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":65},"NCT00211536","Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration","COMPLETED",[39],"2004-08","2008-09","2002-06",107,[15],[44,66],"Aventis HOE21PH U400",{"trials":68,"activeCount":11},[],{"trials":70,"activeCount":11},[],{"intervention":66,"totalTrials":45,"cells":72},{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":85,"NA":87},{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[81],{"nctId":56,"briefTitle":57,"status":58,"phases":82,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":83,"interventions":84},[39],[15],[44,66],{"trials":86,"activeCount":11},[],{"trials":88,"activeCount":11},[],{"intervention":90,"totalTrials":45,"cells":91},"Acetominophen",{"EARLY_PHASE1":92,"PHASE1":94,"PHASE2":96,"PHASE3":98,"PHASE4":100,"NA":102},{"trials":93,"activeCount":11},[],{"trials":95,"activeCount":11},[],{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[104],{"nctId":105,"briefTitle":106,"status":58,"phases":107,"primaryCompletion":108,"completion":108,"start":109,"enrollment":110,"conditions":111,"interventions":112},"NCT04378114","Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults",[41],"2020-07-17","2020-05-18",104,[18,26],[90]]